Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (13)	7/11/1998 7:48:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1475

Harold: The Board is top notch, IMO. Jim Silverman has met the management team, and I think that he liked them. The <outside> scientific drive is provided by David Sachs, and he's a hero of mine. Same indications as anti-CD40 ligand. I don't know how to compare them, other than to wait for data. I am, however, throwing the abstract up in front of the eyes of a bunch of CD40L fans. I'll comment if I get anything useful. No, BTRN can't pipeline a product like BGEN (etc.) can, but MEDI is damn good at it, thus far. Thanks for poking around. Rick